AXA to hand second fund to Game

AXA Framlington is to hand Deane Donnigan's Biotech fund to Gemma Game following her shock departure.

The group confirmed Donnigan, who is leaving at the end of June, will offload the portfolio to Game. Game has already taken control of the £263m AXA Framlington Health fund. Donnigan has only run the £39m Biotech fund, launched a decade ago, since last June, after former manager Andy Smith left the firm. A spokeswoman says global head of AXA Framlington Mark Beveridge would work closely with the team running the funds until Donnigan leaves. The group has previously says it is actively looking to recruit a new member for the team. The fund’s remit – to provide returns to investor...